Dr. Edward Fox provides deeper insight into the relapse data for TECFIDERA in clinical trials and the importance of their implications.
Dr. Aaron Boster discusses physical disability progression in RMS and how he works to delay its course.
Dr. David Hojnacki shares the value of MRIs in RMS therapy and how he utilizes them in his practice.
Drs. Jeffrey Dunn, Ann Cabot, Barbara O’Connell, and Joshua Katz go over the important conversations they have with their RMS patients during therapy selection and initiation.
Drs. Jeffrey Dunn and Ann Cabot review key checkpoints and tips for their RMS patients after they’ve started therapy.
*All videos were edited to comply with applicable laws and regulations.